Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ClearPoint Neuro, Inc. | Financial_Report.xls |
| EX-10.1 - EXHIBIT 10.1 - ClearPoint Neuro, Inc. | ex10-1.htm |
| EX-31.2 - EXHIBIT 31.2 - ClearPoint Neuro, Inc. | ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - ClearPoint Neuro, Inc. | ex31-1.htm |
| EX-10.3 - EXHIBIT 10.3 - ClearPoint Neuro, Inc. | ex10-3.htm |
| EX-10.4 - EXHIBIT 10.4 - ClearPoint Neuro, Inc. | ex10-4.htm |
| EX-10.2 - EXHIBIT 10.2 - ClearPoint Neuro, Inc. | ex10-2.htm |
| EX-10.5 - EXHIBIT 10.5 - ClearPoint Neuro, Inc. | ex10-5.htm |
| 10-Q - FORM 10-Q - ClearPoint Neuro, Inc. | mrii20150331_10q.htm |
Exhibit 32
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(b) UNDER
THE SECURITIES EXCHANGE ACT OF 1934 AND SECTION 1350 OF
CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE
Each of the undersigned, Francis P. Grillo and David W. Carlson, certifies pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, that (1) this quarterly report on Form 10-Q for the quarter ended March 31, 2015, of MRI Interventions, Inc. (the “Company”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and (2) the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 7, 2015
|
/s/ Francis P. Grillo | |
|
Francis P. Grillo | |
|
Chief Executive Officer | |
|
/s/ David W. Carlson | |
|
David W. Carlson | |
|
Chief Financial Officer |